Last reviewed · How we verify

NCT03611842: MMP and OME

Study of the Expression of MMPs in OME in Children With Atrophy of the Eardrum

Completed Last updated 19 April 2019
What this trial tests

trial testing preservation of mucosal otitis media in Otitis Media With Effusion in 35 participants. Completed in 30 November 2018.

Timeline
30 September 2018
Primary endpoint
1 November 2018
30 November 2018

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusCompleted
Study typeOBSERVATIONAL
Enrollment35
Start date30 September 2018
Primary completion1 November 2018
Estimated completion30 November 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

Under 12, any sex, with Otitis Media With Effusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Metalloproteinases (MMPs) constitute a family of endopeptidases that cleaves the extracellular matrix as collagen included in the eardrum. Activity of MMP has been shown in some otitis media with effusion (OME) fluids. These enzymes could be directly linked to the prosnostic of OME as it may damage the eardrum and leads to tympanic atrophy. The main goal of the study is to find out the correlation between activity of MMPs and tympanic atrophy. The investigator will also study if there is any clinical predictive factors in relation to the level of MMPs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Otitis Media With Effusion

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03611842.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing